Drug‐induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase‐IV inhibitors plus metformin (Q51581916)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 6, 2011

edit

Language	Label	Description	Also known as
English	Drug‐induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase‐IV inhibitors plus metformin	scientific article published on April 6, 2011

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21466592

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/21466592

title

Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21466592

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/21466592

Drug‐induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase‐IV inhibitors plus metformin (English)

1 reference

stated in

Crossref

DOI

10.1111/J.1468-3083.2011.04062.X

reference URL

https://api.crossref.org/works/10.1111/J.1468-3083.2011.04062.X

retrieved

29 November 2024

main subject

metformin

1 reference

based on heuristic

inferred from title

bullous pemphigoid

1 reference

based on heuristic

inferred from title

author name string

K. Skandalis

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21466592

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21466592

retrieved

29 November 2024

M. Spirova

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21466592

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21466592

retrieved

29 November 2024

G. Gaitanis

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21466592

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21466592

retrieved

29 November 2024

A. Tsartsarakis

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21466592

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21466592

retrieved

29 November 2024

I. D. Bassukas

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21466592

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21466592

retrieved

29 November 2024

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

21466592

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21466592

retrieved

29 November 2024

publication date

6 April 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21466592

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/21466592

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1468-3083.2011.04062.x

1 reference

stated in

Crossref

DOI

10.1111/J.1468-3083.2011.04062.X

reference URL

https://api.crossref.org/works/10.1111/J.1468-3083.2011.04062.X

retrieved

29 November 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1468-3083.2011.04062.x

1 reference

stated in

Crossref

DOI

10.1111/J.1468-3083.2011.04062.X

reference URL

https://api.crossref.org/works/10.1111/J.1468-3083.2011.04062.X

retrieved

29 November 2024

published in

Journal of the European Academy of Dermatology and Venereology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21466592

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/21466592

volume

26

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21466592

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/21466592

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21466592

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/21466592

page(s)

249-253

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21466592

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/21466592

cites work

Incretin-based therapies for type 2 diabetes mellitus

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04062.X

retrieved

21 January 2018

Seprase: an overview of an important matrix serine protease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04062.X

retrieved

21 January 2018

The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04062.X

retrieved

21 January 2018

Glucagon-like peptide-1 receptor and proglucagon expression in mouse skin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04062.X

retrieved

21 January 2018

Sitagliptin-associated drug allergy: review of spontaneous adverse event reports

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04062.X

retrieved

21 January 2018

Safety and tolerability of vildagliptin vs. thiazolidinedione as add-on to metformin in type 2 diabetic patients with and without mild renal impairment: a retrospective analysis of the GALIANT study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04062.X

retrieved

21 January 2018

CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04062.X

retrieved

21 January 2018

Inhibition of multifunctional dipeptidyl peptidase-IV: is there a risk of oncological and immunological adverse effects?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04062.X

retrieved

21 January 2018

Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04062.X

retrieved

21 January 2018

Dipeptidylpeptidase-4 inhibitors (gliptins): focus on drug-drug interactions

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04062.X

retrieved

21 January 2018

Inhibition of CD26/dipeptidyl peptidase IV enhances CCL11/eotaxin-mediated recruitment of eosinophils in vivo.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04062.X

retrieved

21 January 2018

Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04062.X

retrieved

21 January 2018

Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04062.X

retrieved

21 January 2018

Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04062.X

retrieved

21 January 2018

IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04062.X

retrieved

21 January 2018

Risk factors for bullous pemphigoid in the elderly: a prospective case-control study

series ordinal

11

1 reference

stated in

Crossref

DOI

10.1111/J.1468-3083.2011.04062.X

reference URL

https://api.crossref.org/works/10.1111/J.1468-3083.2011.04062.X

retrieved

29 November 2024

Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting

series ordinal

19

1 reference

stated in

Crossref

DOI

10.1111/J.1468-3083.2011.04062.X

reference URL

https://api.crossref.org/works/10.1111/J.1468-3083.2011.04062.X

retrieved

29 November 2024

Identifiers

DOI

10.1111/J.1468-3083.2011.04062.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21466592

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/21466592

PubMed publication ID

21466592

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21466592

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/21466592

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51581916&oldid=2281065551"